AT348695B - Verfahren zur herstellung von neuen 7-hydroxy- oestradiolen - Google Patents

Verfahren zur herstellung von neuen 7-hydroxy- oestradiolen

Info

Publication number
AT348695B
AT348695B AT775475A AT775475A AT348695B AT 348695 B AT348695 B AT 348695B AT 775475 A AT775475 A AT 775475A AT 775475 A AT775475 A AT 775475A AT 348695 B AT348695 B AT 348695B
Authority
AT
Austria
Prior art keywords
oestradiols
hydroxy
manufacturing new
manufacturing
new
Prior art date
Application number
AT775475A
Other languages
English (en)
Other versions
ATA775475A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449327A external-priority patent/DE2449327C2/de
Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de
Application filed by Schering Ag filed Critical Schering Ag
Priority to AT909877A priority Critical patent/AT357706B/de
Publication of ATA775475A publication Critical patent/ATA775475A/de
Application granted granted Critical
Publication of AT348695B publication Critical patent/AT348695B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/912—Absidia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT775475A 1974-10-14 1975-10-10 Verfahren zur herstellung von neuen 7-hydroxy- oestradiolen AT348695B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT909877A AT357706B (de) 1974-10-14 1977-12-19 Verfahren zur herstellung von neuen 7alfa- hydroxy-oestradiolen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449327A DE2449327C2 (de) 1974-10-14 1974-10-14 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de) 1975-08-08 1975-08-08 7-hydroxy-oestradiole

Publications (2)

Publication Number Publication Date
ATA775475A ATA775475A (de) 1978-07-15
AT348695B true AT348695B (de) 1979-02-26

Family

ID=25767825

Family Applications (1)

Application Number Title Priority Date Filing Date
AT775475A AT348695B (de) 1974-10-14 1975-10-10 Verfahren zur herstellung von neuen 7-hydroxy- oestradiolen

Country Status (23)

Country Link
US (1) US4011314A (de)
JP (1) JPS5165747A (de)
AT (1) AT348695B (de)
CA (1) CA1054143A (de)
CH (2) CH619240A5 (de)
CS (2) CS205009B2 (de)
DD (1) DD125588A5 (de)
DK (1) DK135378C (de)
ES (1) ES441784A1 (de)
FI (1) FI54603C (de)
FR (1) FR2287908A1 (de)
GB (1) GB1528796A (de)
HU (1) HU176715B (de)
IE (1) IE42167B1 (de)
IL (1) IL48276A (de)
NL (1) NL7512041A (de)
NO (1) NO140824C (de)
NZ (1) NZ178886A (de)
PH (1) PH13802A (de)
PL (2) PL103989B1 (de)
SE (1) SE405254B (de)
SU (2) SU676170A3 (de)
YU (2) YU243975A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
EP0954317B1 (de) 1996-04-09 2007-06-06 The University Of Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
WO2001023405A2 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
EP1624878B1 (de) * 2003-05-22 2006-09-27 Pantarhei Bioscience B.V. Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115444A (en) * 1962-01-22 1963-12-24 Olin Mathieson Process for microbial hydroxylation of steroids containing aromatic alpha-rings

Also Published As

Publication number Publication date
JPS5165747A (en) 1976-06-07
HU176715B (en) 1981-04-28
FI54603B (fi) 1978-09-29
IL48276A (en) 1979-03-12
CH619268A5 (de) 1980-09-15
CS205010B2 (en) 1981-04-30
DK135378B (da) 1977-04-18
GB1528796A (en) 1978-10-18
YU294281A (en) 1982-06-30
CA1054143A (en) 1979-05-08
ATA775475A (de) 1978-07-15
IE42167B1 (en) 1980-06-18
SE405254B (sv) 1978-11-27
SU676170A3 (ru) 1979-07-25
IE42167L (en) 1976-04-14
PL101461B1 (pl) 1978-12-30
FR2287908B1 (de) 1980-04-30
DK439975A (da) 1976-04-15
SU677666A1 (ru) 1981-11-30
FI54603C (fi) 1979-01-10
CS205009B2 (en) 1981-04-30
NZ178886A (en) 1978-04-28
SE7511438L (sv) 1976-04-15
NO140824B (no) 1979-08-13
PH13802A (en) 1980-10-01
FI752836A (de) 1976-04-15
DK135378C (da) 1977-10-03
CH619240A5 (de) 1980-09-15
YU243975A (en) 1982-06-30
AU8571075A (en) 1977-04-21
DD125588A5 (de) 1977-05-04
US4011314A (en) 1977-03-08
NL7512041A (nl) 1976-04-20
FR2287908A1 (fr) 1976-05-14
PL103989B1 (pl) 1979-07-31
SU677666A3 (en) 1981-11-30
NO753455L (de) 1976-04-20
ES441784A1 (es) 1977-04-01
IL48276A0 (en) 1975-12-31
NO140824C (no) 1979-11-21

Similar Documents

Publication Publication Date Title
ATA689275A (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT337363B (de) Verfahren zur herstellung von neuen daunomycinanaloga
AT342769B (de) Verfahren zur herstellung von neuen 1-oxacephemen
ATA427975A (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT336555B (de) Verfahren zur herstellung von neuen athoxylierten hydroxyathern
AT350064B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA247775A (de) Verfahren zur herstellung von neuen acylureidocephalosporinen
ATA412175A (de) Verfahren zur herstellung von neuen biguaniden
AT337668B (de) Verfahren zur herstellung von neuen diphenylathern
AT348695B (de) Verfahren zur herstellung von neuen 7-hydroxy- oestradiolen
AT338773B (de) Verfahren zur herstellung von neuen aminotetralolverbindungen
AT337672B (de) Verfahren zur herstellung von neuen abietamidderivaten
AT337897B (de) Verfahren zur herstellung von neuen acylderivaten
AT351555B (de) Verfahren zur herstellung von neuen nitro- soharnstoff-derivaten
AT351685B (de) Verfahren zur herstellung von neuen cyclopentanderivaten
AT339334B (de) Verfahren zur herstellung von neuen organosiliciumverbindungen
AT339333B (de) Verfahren zur herstellung von neuen organosiliciumverbindungen
ATA783575A (de) Verfahren zur herstellung von neuen nitrofurylverbindungen
AT351686B (de) Verfahren zur herstellung von neuen d-homo-20- ketopregnanen
AT333958B (de) Verfahren zur herstellung von neuen cephalosporinantibiotica
AT331423B (de) Verfahren zur herstellung von neuen desglucohellebrin-derivaten
ATA103077A (de) Verfahren zur herstellung von neuen indol-2- carbaldehyden
ATA749074A (de) Verfahren zur herstellung von neuen pyridylthioharnstoffen
ATA809675A (de) Verfahren zur herstellung von neuen pyridylthioharnstoffen
ATA909877A (de) Verfahren zur herstellung von neuen 7alfa- hydroxy-oestradiolen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee